How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion powerhouse that’s poised to reshape biotech

How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion powerhouse that’s poised to reshape biotech

November 23, 2020 Darnetta Mahaffy 0

Summary List Placement In January, Stéphane Bancel, the chief executive of Moderna, was skimming through the news on his iPad while vacationing with his family in the south of France. A headline stopped his finger: “Health Officials Work to Solve China’s Mystery Virus Outbreak,” The Wall Street Journal reported on January 6. The Frenchman, who…